Почетна › Метастатски карцином › Мериленд
Клинички испитувања за Метастатски карцином во Мериленд
47 студии за Метастатски карцином бараат учесници на локации во Мериленд.
Градови во Мериленд
Официјален текст на студијата (англиски)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Walter Reed National Military Medical Center, Bethesda
- National Institutes of Health Clinical Center, Bethesda
- и уште 1
Се регрутираФаза 2
Сите возрасти · Сите полови · Ажурирано 2.10.2026 · NCT05564377Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Maryland Oncology, Columbia
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07562152Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Greater Baltimore Medical Center, Baltimore
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07222800Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Maryland Oncology Hematology, P.A., Annapolis
- Maryland Oncology Hematology, P.A., Bethesda
- Maryland Oncology Hematology, P.A., Brandywine
- и уште 5
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07222566A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- JHU Oncology Central Kit Services, Baltimore
- Johns Hopkins Hospital, Baltimore
- Oncology Investigational Drug Service (IDS), Baltimore
- и уште 1
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06989437A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Columbia
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06103864Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
- John Hopkins University, Baltimore
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT06915753A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Johns Hopkins Hospital, Baltimore
- James M Stockman Cancer Institute, Frederick
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- American Oncology Partners, PA, Bethesda
- James M Stockman Cancer Institute, Frederick
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07174336A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital Of Baltimore, Baltimore
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07213804Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT06606990The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
- National Institutes of Health Clinical Center, Bethesda
Се регрутираФаза 2
Возраст од 18 до 98 · Сите полови · Ажурирано 16.9.2026 · NCT04927416Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT03907475The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
- National Institutes of Health Clinical Center, Bethesda
Се регрутираФаза 2
Возраст од 18 до 90 · Сите полови · Ажурирано 9.9.2026 · NCT03841617NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
- Johns Hopkins, Baltimore
Се регрутираФаза 1
Возраст 19 и постари · Сите полови · Ажурирано 8.9.2026 · NCT07563829A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Johns Hopkins Bayview Medical Center, Baltimore
- USO - Maryland Oncology Hematology, Columbia
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06119581Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT06072612T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- National Institutes of Health Clinical Center, Bethesda
Се регрутираФаза 2
Возраст од 18 до 72 · Сите полови · Ажурирано 31.8.2026 · NCT02133196Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 24.8.2026 · NCT05687136FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Johns Hopkins Kimmel Cancer Center, Baltimore
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 20.8.2026 · NCT05614739A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Research Site, Baltimore
Се регрутираФаза 2
Возраст од 18 до 130 · Сите полови · Ажурирано 18.8.2026 · NCT06792695FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT05919264Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 13.8.2026 · NCT05691517Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 3.8.2026 · NCT05687110Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 31.7.2026 · NCT05691491A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Maryland Oncology Hematology - Primary, Columbia
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 30.7.2026 · NCT04657068Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Baltimore
- Research Site, Baltimore
- Research Site, Silver Spring
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 29.7.2026 · NCT07044336REMASTer: REcurrent Brain Metastases After SRS Trial
- University of Maryland, Baltimore
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 18.6.2026 · NCT05124912E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- National Institutes of Health Clinical Center, Bethesda
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 12.6.2026 · NCT05686226Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Advanced Molecular Imaging and Therapy, Glen Burnie
- United Theranostics - Chesapeake, Glen Burnie
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 11.6.2026 · NCT05283330Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Johns Hopkins University, Baltimore
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 3.6.2026 · NCT06040541Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
- University of Maryland, Baltimore
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.6.2026 · NCT04617522A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- John Hopkins University, Baltimore
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 27.5.2026 · NCT05384626Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- American Oncology Partners, P.A., Bethesda
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 18.5.2026 · NCT06757634Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Johns Hopkins University, Baltimore
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 15.5.2026 · NCT05379985Studying TAK-243 in Patients With Advanced Cancer
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 13.5.2026 · NCT06223542Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- The Center for Cancer and Blood Disorders, Bethesda
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 8.5.2026 · NCT06697301A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Johns Hopkins University, Baltimore
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.4.2026 · NCT07020221A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- University of Maryland, Baltimore
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 9.4.2026 · NCT06064877Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Се регрутираФаза 2/3
Возраст 18 и постари · Мажи · Ажурирано 8.4.2026 · NCT04787744Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.